BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29193683)

  • 1. Prognostic value of urinary 11-dehydro-thromboxane B
    Vasudevan A; Tecson KM; Bennett-Firmin J; Bottiglieri T; Lopez LR; Peterson M; Sathyamoorthy M; Schiffmann R; Schussler JM; Swift C; Velasco CE; McCullough PA
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):653-658. PubMed ID: 29193683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual thromboxane activity and oxidative stress: influence on mortality in patients with stable coronary artery disease.
    Vasudevan A; Bottiglieri T; Tecson KM; Sathyamoorthy M; Schussler JM; Velasco CE; Lopez LR; Swift C; Peterson M; Bennett-Firmin J; Schiffmann R; McCullough PA
    Coron Artery Dis; 2017 Jun; 28(4):287-293. PubMed ID: 28005558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary 11-Dehydro-Thromboxane B
    McCullough PA; Vasudevan A; Sathyamoorthy M; Schussler JM; Velasco CE; Lopez LR; Swift C; Peterson M; Bennett-Firmin J; Schiffmann R; Bottiglieri T
    Am J Cardiol; 2017 Apr; 119(7):972-977. PubMed ID: 28139223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between the level of the urinary 11-dehydrothromboxane B2 and the clinical efficacy of aspirin in patients with type 2 diabetes and coronary artery disease].
    Liu TF; Zhang JW; Chen XH; Feng XR; Bai ZS; Liu ML
    Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 47(6):920-4. PubMed ID: 26679651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
    Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
    Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery.
    Kakouros N; Gluckman TJ; Conte JV; Kickler TS; Laws K; Barton BA; Rade JJ
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor.
    Ikonomidis I; Andreotti F; Nihoyannopoulos P
    Heart; 2004 Apr; 90(4):389-93. PubMed ID: 15020512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events.
    Thomson VS; John B; George P; Joseph G; Jose J
    J Postgrad Med; 2009; 55(4):252-6. PubMed ID: 20083870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
    Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress reflected by increased F
    McCullough PA; Vasudevan A; Lopez LR; Swift C; Peterson M; Bennett-Firmin J; Schiffmann R; Bottiglieri T
    Thromb Res; 2016 Dec; 148():85-88. PubMed ID: 27815971
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease.
    Lopez LR; Guyer KE; Torre IG; Pitts KR; Matsuura E; Ames PR
    World J Diabetes; 2014 Apr; 5(2):115-27. PubMed ID: 24748925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
    Eikelboom JW; Hirsh J; Weitz JI; Johnston M; Yi Q; Yusuf S
    Circulation; 2002 Apr; 105(14):1650-5. PubMed ID: 11940542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polymorphism and type II diabetes on aspirin resistance in patients with unstable coronary artery disease.
    Gao F; Wang ZX; Men JL; Ren J; Wei MX
    Chin Med J (Engl); 2011 Jun; 124(11):1731-4. PubMed ID: 21740787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery.
    Kakouros N; Nazarian SM; Stadler PB; Kickler TS; Rade JJ
    J Am Heart Assoc; 2016 Mar; 5(3):e002615. PubMed ID: 27068626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.
    Santilli F; Paloscia L; Liani R; Di Nicola M; Di Marco M; Lattanzio S; La Barba S; Pascale S; Mascellanti M; Davì G
    J Am Heart Assoc; 2014 Jul; 3(4):. PubMed ID: 25037196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference interval establishment and correlation research of urine thromboxane metabolites: Unveiling new possibilities in platelet activation.
    Cao Y; Zhao F; Wang S; Li Y; Li S; Cui X
    Clin Chim Acta; 2024 May; 558():119672. PubMed ID: 38621589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
    Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
    Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of urinary 11-dehydro-thromboxane B
    Simeone P; Boccatonda A; Liani R; Santilli F
    Ageing Res Rev; 2018 Dec; 48():51-78. PubMed ID: 30273676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.